Low [Mg2+]e Enhances Arterial Spontaneous Tone via Phosphatidylinositol 3-Kinase in DOCA-Salt Hypertension

Hypertension

Volumn 43, Issue 1, 2004, Pages 125-130

  Northcott, Carrie A ^a   Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Deoxycorticosterone; Hypertension, sodium dependent; Kinase; Magnesium; Phosphorylation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; DEOXYCORTICOSTERONE ACETATE; MAGNESIUM ION; NORADRENALIN; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; AORTA STRIP; ARTERY TONE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERTENSION; MAGNESIUM DEFICIENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0348049453     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000103631.68328.03     Document Type: Article

References (34)

1. Northcotl CA, Poy MN, Najjar SM, Watts SW. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circ Res. 2002;91:360-369.
2. 2+ channels. Circ Res. 2001;89:692-699.
3. 2+ channels via phosphoinositide 3-kinase. FASEB J. 1999;13:685-694.
4. Yang ZW, Wang J, Zheng T, Altura BT, Altura BM. Importance of PKC and PI3Ks in ethanol-induced contraction of cerebral arterial smooth muscle. Am J Physiol Heart Circ Physiol. 2001;280:H2144-H2152.
5. Yang Z, Wang J, Altura BT, Altura BM. Extracellular magnesium deficiency induces contraction of arterial muscle: role of PI3-kinases and MAPK signaling pathways. Pflugers Arch. 2000;439:240-247.
6. 2+, PKC, and PI3. Am J Physiol Heart Circ Physiol. 2000;279:H2898-H2907.
7. Johnson S. The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses. 2001;56:163-170.
8. Facts About Dietaty Supplements. Clinical Nutrition Service. Warren Grant Magnuson Clinical Center, Office of Dietary Supplements, National Institutes of Health. Washington, DC: National Institutes of Health; March 2001.
9. Touyz RM. Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med. 2003;24:107-136.
10. Laurant P, Touyz RM. Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. J Hypertens. 2000;18:1177-1191.
11. Rusch NJ, Kotchen TA. Vascular smooth muscle regulation by calcium, magnesium and potassium in hypertension. In: Swales JD, ed. Textbook of Hypertension. Oxford, England: Blackwell Scientific Publishers: 1994:188-199.
12. Laurant P, Touyz RM, Schiffrin EL. Effect of magnesium on vascular tone and reactivity in pressurized mesenteric resistance arteries from spontaneously hypertensive rats. Can J Physiol Pharmacol 1997;75:293-300.
13. Laurant P, Berthelot A. Influence of endothelium in the in vitro vasorelaxant effect of magnesium on aortic basal tension in DOCA-salt hypertensive rat. Magnes Res. 1992;5:255-260.
14. Touyz RM, Marshall PR, Milne FJ. Altered cations and muscle membrane ATPase activity in deoxycorticosterone acetate-salt spontaneously hypertensive rats. J Hypertens. 1991;9:737-750.
15. Berthon N, Laurant P, Fellmann D, Berthelot A. Effect of magnesium on mRNA expression and production of endothelin-1 in DOCA-salt hypertensive rats. J Cardiovasc Pharmacol. 2003;42:24-31.
16. DiPette DJ, Simpson K, Guntupalli J. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state. Magnesium. 1987;6:136-149.
17. Kh R, Khullar M, Kashyap M, Pandhi P, Uppal R. Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats. J Hypertens. 2000;18:919-926.
18. Laurant P, Kantelip JP, Berthelot A. Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats. J Nutr. 1995;125:830-841.
19. e induces contraction of cerebral arteries: roles of tyrosine and mitogen-activated protein kinases. Am J Physiol Heart Circ Physiol. 2000;279:H185-H194.
20. 2+? Eur J Pharmacol. 2001;413:R1-R3.
21. Wei SK, Quigley JF, Hanlon SU, O'Rourke B, Haigney MC. Cytosolic free magnesium modulates Na/Ca exchange currents in pig myocytes. Cardiovasc Res. 2002;53:334-340.
22. 2+ channels in smooth muscle and endothelial cells of human allantochorial placental vessels. Magnes Res. 2001;14:11-18.
23. Altura BM, Zhang A, Cheng TP, Altura BT. Extracellular magnesium regulates nuclear and perinuclear free ionized calcium in cerebral vascular smooth muscle cells: possible relation to alcohol and central nervous system injury. Alcohol. 2001;23:83-90.
24. Touyz RM, Laurant P, Schiffrin EL. Effect of magnesium on calcium responses to vasopressin in vascular smooth muscle cells of spontaneously hypertensive rats. J Pharmacol Exp Ther. 1998;284:998-1005.
25. Florian JA, Watts SW. Epidermal growth factor: a potent vasoconstrictor in experimental hypertension. Am J Physiol. 1999;276:H976-H983.
26. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF, Accili D. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest. 2000;105:199-205.
27. Poy MN, Ruch RJ, Fernstrom MA, Okabayashi Y, Najjar SM. Shc and CEACAM1 interact to regulate the mitogenic action of insulin. J Biol Chem. 2002;277:1076-1084.
28. Saito N, Abbu GC, Konishi Y, Nishiyama S, Okada T. Magnesium, calcium and trace elements in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl. 1995;22:S212-S214.
29. Wells IC, Agrawal DK. Abnormal magnesium metabolism in two rat models of genetic hypertension. Can J Physiol Pharmacol. 1992;70:1225-1229.
30. Sasaki S, Oshima T, Matsuura H, Ozono R, Higashi Y, Saski N, Matsumoto T, Nakano Y, Ueda A, Yoshimizu A, Kurisu S, Kambe M, Kajiyama G. Abnormal magnesium status in patients with cardiovascular diseases. Clin Sci. 2000;98:175-181.
31. Fox C, Ramsoomair D, Carter C. Magnesium: its proven and potential clinical significance. South Med J. 2001;94:1195-1201.
32. Resnick LM, Bardicef O, Altura BT, Alderman MH, Altura BM. Serum ionized magnesium: relation to blood pressure and racial factors. Am J Hypertens. 1997;10:1420-1424.
33. Resnick LM, Gupta RK, Laragh JH. Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc Natl Acad Sci U S A. 1984;81:6511-6515.
34. 2+ in aortic and cerebral vascular smooth muscle cells: possible links to hypertension, atherogenesis, and stroke. Am J Hypertens. 2003;16:701-707.